Royal Bank of Canada Increases Huntsman (NYSE:HUN) Price Target to $24.00

Huntsman (NYSE:HUN) had its price objective upped by research analysts at Royal Bank of Canada from $21.00 to $24.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has a “sector perform” rating on the basic materials company’s stock. Royal Bank of Canada’s price objective suggests a potential upside of 0.25% from the stock’s previous close.

HUN has been the subject of several other reports. JPMorgan Chase & Co. cut their target price on shares of Huntsman from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. Citigroup decreased their price objective on shares of Huntsman from $26.00 to $24.00 and set a “neutral” rating for the company in a research report on Thursday, June 27th. Wells Fargo & Company dropped their target price on Huntsman from $28.00 to $26.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. Finally, UBS Group reduced their price target on Huntsman from $23.00 to $22.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. One analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $25.89.

Huntsman Trading Up 0.8 %

NYSE HUN opened at $23.94 on Friday. Huntsman has a 1 year low of $19.91 and a 1 year high of $27.01. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.30 and a quick ratio of 0.77. The company has a market capitalization of $4.14 billion, a PE ratio of -46.04 and a beta of 1.00. The company has a fifty day moving average of $22.13 and a 200 day moving average of $23.35.

Huntsman (NYSE:HUN) last issued its quarterly earnings data on Monday, August 5th. The basic materials company reported $0.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.14. The business had revenue of $1.57 billion during the quarter, compared to analysts’ expectations of $1.61 billion. Huntsman had a positive return on equity of 0.26% and a negative net margin of 1.44%. The company’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.22 EPS. Research analysts forecast that Huntsman will post 0.19 earnings per share for the current year.

Institutional Trading of Huntsman

A number of institutional investors have recently made changes to their positions in HUN. Creative Planning lifted its holdings in Huntsman by 16.0% in the 3rd quarter. Creative Planning now owns 28,925 shares of the basic materials company’s stock valued at $700,000 after purchasing an additional 3,997 shares in the last quarter. Wesbanco Bank Inc. acquired a new stake in shares of Huntsman in the third quarter valued at about $242,000. Matrix Trust Co purchased a new position in shares of Huntsman in the third quarter worth about $25,000. CWM LLC boosted its position in Huntsman by 390.9% during the third quarter. CWM LLC now owns 49,160 shares of the basic materials company’s stock worth $1,190,000 after acquiring an additional 39,145 shares during the last quarter. Finally, Handelsbanken Fonder AB grew its stake in Huntsman by 43.2% during the 3rd quarter. Handelsbanken Fonder AB now owns 45,113 shares of the basic materials company’s stock valued at $1,092,000 after acquiring an additional 13,600 shares in the last quarter. 84.81% of the stock is owned by institutional investors and hedge funds.

About Huntsman

Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.